Rochester Medical Corporation (ROCM)
Q3 2012 Earnings Call
July 27, 2012 11:00 a.m. ET
Anthony J. Conway – President & CEO
David Jonas – CFO
Good day, ladies and gentlemen, and welcome to the Third Quarter 2012 Rochester Medical Corp. Earnings Conference Call. My name is Jasmine, and I will be your coordinator for today. At this time, all participants are in a listen-only mode, we will be facilitating a question-and-answer session towards the end of today
s conference. (Operator
s Instructions) As a reminder, this conference is being recorded for replay purposes.
I would now like to turn the presentation over to your host for today
s conference Mr. Anthony J. Conway, President and CEO. You may proceed.
Good morning. Thank you for joining Rochester Medical
s third quarter conference call. I
m Jim Conway, the company
s President and CEO. And with me is David Jonas, Rochester Medical
s Chief Financial Officer.
First, I will provide a brief high level review of our third quarter and Dave will then provide you with more details on our financial results, and then I
ll give a quick update on a few items and summarize, and we will take your questions.
Before starting, let me remind you that we will be making some forward-looking statements today, and I would refer you to the Safe Harbor statement found in today
s press release and also to the Risk Factors section in the company
s Annual Report on Form 10-K for the year ended September 30, 2011. These statements further clarify the risks and uncertainties that are associated with the forward-looking statements.
Okay. In total revenues grew 7% on a reported basis and 10% on a constant currency basis to a total of $15.3 million. Our goal of direct sales business had 9% constant currency growth with the U.S. direct sales business leading the way with a robust 34% increase, paced by good strength in our Home Care market.